Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. [electronic resource]
Producer: 20180221Description: 461-474 p. digitalISSN:- 1573-7217
- ATP Binding Cassette Transporter, Subfamily G, Member 2 -- genetics
- Breast Neoplasms -- drug therapy
- Calpain -- genetics
- Carcinoembryonic Antigen -- genetics
- Cell Plasticity -- genetics
- Cell Proliferation -- genetics
- Drug Resistance, Neoplasm -- genetics
- E1A-Associated p300 Protein -- genetics
- Female
- GPI-Linked Proteins -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lentivirus -- genetics
- MCF-7 Cells
- Neoplasm Metastasis
- Neoplasm Proteins -- genetics
- Neoplastic Stem Cells -- metabolism
- Paclitaxel -- administration & dosage
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Transforming Growth Factor beta2 -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.